Clinical Trials Browser

Phase 2/3 × OTHER × liposomal doxorubicin × Clear all

NCT06791460 2025-03-18

Pegylated Liposomal Doxorubicin Plus Adebrelimab With or Without Mirabegron in Relapsed Ovarian Cancer

Phase 2/3 Recruiting

Ovarian Cancer Recurrent

NCT03342300 2020-05-19

PDVPSTS

Phase 2/3 Withdrawn

Sarcoma

NCT02527772 2019-06-04

LD-FOX4/HCC

Phase 2/3 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular